Gonda 8-104/Joseph 1-242

Resident Recruitment Interview Day

Michelle Mauermann, M.D.
"New Frontiers in TTR Amyloidosis"

Learning objectives:
Recognize the clinical presentation of TTR amyloidosis
Identify the importance of choosing clinical endpoints in clinical trials
Apply new treatments for TTR amyloidosis

The presenter has the following relevant financial relationship to disclose:
Advisory Committee - IONIS
The presenter intends to discuss off-label/investigative uses of the following commercial products/devices:
Diflunisal, Patisiran, IONIS-TTRx, monoclonal antibodies against SAP